Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Equity (2016 - 2025)

Historic Return on Equity for Macrogenics (MGNX) over the last 13 years, with Q3 2025 value amounting to 1.37%.

  • Macrogenics' Return on Equity fell 2000.0% to 1.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.37%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.5% for FY2024, which is 4400.0% down from last year.
  • Macrogenics' Return on Equity amounted to 1.37% in Q3 2025, which was down 2000.0% from 0.61% recorded in Q2 2025.
  • Over the past 5 years, Macrogenics' Return on Equity peaked at 0.39% during Q2 2021, and registered a low of 2.38% during Q2 2024.
  • Moreover, its 5-year median value for Return on Equity was 0.76% (2021), whereas its average is 0.95%.
  • Per our database at Business Quant, Macrogenics' Return on Equity tumbled by -16900bps in 2024 and then soared by 17800bps in 2025.
  • Macrogenics' Return on Equity (Quarter) stood at 0.76% in 2021, then decreased by -20bps to 0.92% in 2022, then decreased by -7bps to 0.98% in 2023, then soared by 40bps to 0.59% in 2024, then crashed by -131bps to 1.37% in 2025.
  • Its Return on Equity was 1.37% in Q3 2025, compared to 0.61% in Q2 2025 and 0.59% in Q1 2025.